Respiratory Flashcards
Antihistamines
First Gen.
Diphenhydramine, Dimenhydrinate, Chlorpheniramine
MOA: Reversible inhibitors of H1 histamine receptors
Use:
Allergy, motion sickness, sleep aid
Adv. effects:
Sedation, antimuscarinic (flushed skin, mydriasis), anti-alpha-adrenergic
Antihistamines
Second Gen.
Loratadine, Fexofenadine, Desloratidine, Cetrizine
MOA: Reversible inhibitors of H1 histamine receptors
Use: Allergy
Adv. effects:
Far less sedating than 1st gen because of decreased entry into CNS
Guaifenesin
Expectorant - thins respiratory secretions; does not suppress cough reflex.
N-acetylcysteine
Mucolytic - liquifies mucus in COPD patients by disrupting disulfide bonds.
Used as an antidote for acetaminophen overdose
Dextromethorphan
Antitussive (antagonizes NMDA glutamate receptors)
Synthetic codeine analog
Mild opioid effect (when used in excess)
Overdose treated wuth Naloxone
Mild abuse potential
May cause serotonin syndrome if combined w. other serotonergic agents
Pseudoephedrine, Phenylephrine
MOA:
alpha-adrenergic agonists, used as nasal decongestants
Use: Reduce hyperemia Edema Nasal congestion Open obstructed eustachian tubes Pseudoephedrine used illicitly to make methamphetamine
Adv. effects:
Hypertension
CNS stimulation/anxiety (pseudoephedrine)
Bosentan
MOA:
Competitively antagonizes endothelin-1 receptors –> decreases pulmonary vascular resistance
Use: Pulmonary htn
Adv. effects:
Hepatotoxic (monitor LFTs)
Sidenafil
MOA:
Inhibitors cGMP PDE-5 and prolongs vasodilatory effect of nitric oxide
Use:
Pulmonary htn
Erectile dysfunction
Epoprostenol, Iloprost
MOA:
PGI2 (prostacyclin) w/ direct vasodilatory effects on pulmonary and systemic arterial vascular beds
Inhibits platelet aggregation
Use: Pulmonary htn
Adv. effects:
Flushing
Jaw pain
Albuterol
Short acting Beta2 agonist
Use: Asthma; used during acute exacerbation
Relaxes bronchial smooth muscle
Salmeterol, Formoterol
Long acting Beta2 agonist
Use: Asthma prophylaxis
Adv. effects:
tremor
arrhythmia
Inhaled corticosteroids
Fluticasone, Budesonide
MOA:
Inhibit synthesis of all cytokines
Inactivate NF-kB (Transcription factor that induces production of TNF-a and other inflammatory agents)
Use:
first line for chronic asthma
Ipratropium
MOA: competitively blocks muscarinic receptors, preventing bronchoconstriction
Use: COPD
Montelukast, Zafirlukast
Block leukotriene receptors
Good for aspirin induced asthma
Zileuton
MOA:
5-lipoxygenase pathway inhibitor
Blocks conversion of arachidonic acid to leukotrienes
Use: Asthma
Adv. effects:
Hepatotoxic
Omalizumab
MOA: binds unbound serum IgE and blocks binding to FceRI.
Use: Allergic asthma w/ inc. IgE levels resistant to inhaled steroids and long acting beta2 agonists
Theophylline
methylxanthines
MOA:
Causes bronchodilation by inhibiting phosphodiesterase –> increase cAMP levels due to decrease in cAMP hydrolysis
Use: asthma
limited bc of narrow therapuetic index (cardiotoxcitiy, neurotoxicity)
Metabolized by cytochrome P450
Blocks actions of adenosine
Methacholine
Muscarinic receptor (M3) agonist
Used in bronchial challenge test to help diagnose asthma